2cureX AB (publ) (FRA:2QE)

Market Cap	3.04M
Revenue (ttm)	174.00K
Net Income (ttm)	-2.32M
Shares Out	n/a
EPS (ttm)	-0.13
PE Ratio	n/a
Forward PE	n/a
Dividend	0.01 (6.02%)
Ex-Dividend Date	Jun 27, 2025

Volume	n/a
Average Volume	n/a
Open	0.1255
Previous Close	0.1235
Day's Range	0.1255 - 0.1255
52-Week Range	0.0220 - 0.4910
Beta	n/a
RSI	46.44
Earnings Date	Feb 26, 2026

About 2cureX AB

2cureX AB (publ) operates as a medtech company in Europe. The company’s principal product is IndiTreat, an IVD test, which helps to predict cancer patient’s response and resistance to different drugs and select the appropriate treatment. It is also conducting various clinical programs for IndiTreat for colorectal, ovarian, and pancreatic cancers. In addition, the company offers research and consulting services. 2cureX AB (publ) was incorporated in 2006 and is based in Copenhagen, Denmark.

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 2006
• Employees: 14
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 2QE

Financial Performance

In 2023, 2cureX AB's revenue was 2.95 million, a decrease of -12.53% compared to the previous year's 3.37 million. Losses were -32.52 million, 9.23% more than in 2022.

Financial numbers in SEK